Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.

AbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in ...

Addresses the significant threat of antimicrobial resistance.

A sore throat usually isn't serious enough for a trip to the doctor, and many natural remedies can help ease your symptoms, ...

The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in ...

Some bacteria have evolved to beat modern medication - but one natural kitchen cupboard item could be the key to stop them ...

You probably think “antibiotic resistance” means that a bacterial infection can’t be cured by any antibiotics. But the FDA ...

Make your antibiotic medication as effective as possible by getting these answers before you leave the doctor's office or pharmacy.

Hematopoietic stem cell transplantation (HSCT) is a vital treatment for both malignant and non-malignant disorders in pediatric patients.

AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

Researchers have used artificial intelligence to identify 25 new protein compounds that can kill bacteria and fungi, ...